Skip to main content
. 2009 Nov 24;101(11):1869–1875. doi: 10.1038/sj.bjc.6605438

Figure 2.

Figure 2

Kaplan–Meier overall survival (A) and time to progression (B) curves for tryptase MCs counts divided into two groups above and below the median value; Kaplan–Meier overall survival (C) and time to progression (D) curves for Foxp3 counts divided into two groups above and below the median value; (E) Kaplan–Meier overall survival curves for combination of tryptase MCs and Foxp3 counts.